Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    Original Article

    Oleanolic Acid and other Compounds Isolated from Cordia africana Lam which Inhibit Vancomycin Resistant Enterococcus

    wadmin1By wadmin1June 1, 2019Updated:August 10, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    Rahab W. Kamau1,3,*, Jacob O. Midiwo2, Quintino A. Mgani1, Veronica M. Masila2, Leonidah K. Omosa2, Regina N. Bwire3, Melissa R. Jacob4, Frank T. Wiggers4, Ilias Muhammad4

    1Department of Chemistry, College of Natural and Applied Sciences, University of Dar es Salaam, Dar es Salaam, TANZANIA.

    2Department of Chemistry, School of Physical Sciences, University of Nairobi, Nairobi, KENYA.

    3Department of Chemistry, School of Natural and Applied Sciences, Masinde Muliro University of Science and Technology, Kakamega, KENYA.

    4National Centre for Natural Products Research, Research Institute of Pharmaceutical Sciences, School of Pharmacy, University of Mississippi, Mississippi, USA.

    Pharmacognosy Communications,2019,9,3,91-95.
    DOI:10.5530/pc.2019.3.19
    Published:June 2019
    Type:Original Article

    ABSTRACT

    Introduction: Treatment of microbial infections has become complicated due to increased resistance of microbes to the current drugs. The current study investigates crude extracts and seven compounds from root and stem bark of Cordia africana Lam. for antimicrobial and cytotoxic activity. Methods: Extraction was done using 50% methanol in dichloromethane, followed by chromatographic separation of compounds, whose structures were established by interpretation of spectroscopic data. The in vitro susceptibility of selected microbes to the crude extracts and pure compounds was determined. Cytotoxicity of 1, 6 and 7 was determined against the drug sensitive, CCRF-CEM and resistant CEM/ADR-5000 cells, with doxorubicin used as the standard. Results: The root bark extract of C. africana yielded six known compounds: oleanolic acid (1), 3-β-lup-20(29)-en-3-ol (2) stigmast-5,22-dien-3β-ol (3), 2-(2Z) -(3-hydroxy-3,7-dimethylocta-2,6-dienyl)-1,4-benzenediol (4), 4-hydroxy-3-methoxy- benzaldehyde (5) and 7-hydroxy-4′-methoxyisoflavone (6). The stem bark extract resulted to 1 and 2 alongside, ubiquinone-8 (7) and 1-octacosanol (8). Compound 1 showed moderate activity against Enterococcus faecium (IC50 of 14.44 µg/mL), with vancomycin being inactive. Compounds 1, 6 and 7 showed cell viability ˃50% against CEM/ADR5000 and CCRF-CEM cells at 10 µM and therefore were considered inactive. Surprisingly, 1 was relatively more active compared to the standard, with cell viability of 57.93% against CEM/ADR5000, versus 78.97% for doxorubicin. Conclusion: To the best of our knowledge, this is the first report of the eight compounds from C. africana. The cytotoxicity of 1, 6 and 7 are reported here for the first time. Traditional use of the plant extract in management of various infections may be attributed to presence of 1, which displayed moderate antimicrobial activity.

    Keywords:7-hydroxy-4′-methoxyisoflavone, Cordia africana, Oleanolic acid, Ubiquinone-8, VRE
    Download PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up